Multicenter, randomized, placebo-controlled, double-blind, parallel group, dose-finding Phase 2 study to evaluate efficacy and safety of BAY2433334 in patients following an acute non-cardioembolic ischemic stroke (PACIFIC-STROKE).
- Cloud, Geoffrey (Primary Chief Investigator (PCI))
Project: Research